Related Experiment Video
Updated: May 26, 2026
07:09
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
Muscarinic receptor agonists and antagonists: effects on ocular function
1Department of Pharmacology, University of Melbourne, Melbourne, VIC 3010, Australia. fjmitc@unimelb.edu.au
Handbook of Experimental Pharmacology
|January 7, 2012
Summary
Muscarinic agonists, targeting specific receptors, influence eye functions like pupil size and tear production. They also play roles in retinal development and function, with implications for conditions like Sjögren's syndrome and myopia.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Muscarinic agonists interact with various muscarinic receptor subtypes (M₁, M₂, M₃, etc.) to modulate physiological processes.
- These receptors are distributed across ocular tissues, including the iris, ciliary muscle, trabecular meshwork, conjunctiva, lens, retina, and lacrimal gland.
- Dysregulation of muscarinic signaling is implicated in ocular conditions such as Sjögren's syndrome and myopia.
Purpose of the Study:
- To elucidate the diverse roles of muscarinic agonists and their receptors in ocular and related physiological functions.
- To explore the involvement of specific muscarinic receptor subtypes in processes such as aqueous humor outflow, tear secretion, and retinal activity.
- To investigate the potential therapeutic implications of muscarinic receptor modulation in ocular diseases and conditions.
Main Methods:
- Review and synthesis of existing literature on muscarinic agonist pharmacology and physiology in ocular tissues.
- Analysis of receptor-specific effects based on experimental evidence across different species and conditions.
- Examination of clinical observations and therapeutic outcomes related to muscarinic agents and antagonists.
Main Results:
- Muscarinic agonists primarily mediate iris sphincter and ciliary muscle contraction via M₃ receptors, increasing aqueous humor outflow.
- Effects on iris dilator muscles are species-dependent, often involving M₃ receptor-mediated relaxation.
- Muscarinic agonists stimulate goblet cell secretion (M₂/M₃ receptors) for tear film formation and influence retinal neuronal activity (M₁ receptors in the lens, complex effects in the retina).
- Atropine and pirenzepine show efficacy in limiting myopia progression, potentially via scleral muscarinic receptor antagonism.
Conclusions:
- Muscarinic agonists exert multifaceted effects on ocular structures and functions through distinct receptor subtypes.
- Understanding these interactions is crucial for managing conditions like Sjögren's syndrome and myopia.
- Targeting specific muscarinic receptors offers potential therapeutic avenues for various ophthalmological disorders.
Related Concept Videos
01:28Cholinergic Antagonists: Pharmacological Actions
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
01:26Cholinergic Antagonists: Therapeutic Uses
Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
01:24Cholinergic Antagonists: Pharmacokinetics
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...